Can a cancer drug tame rare mast cell disease?
NCT ID NCT00769587
First seen Sep 30, 2025 · Last updated May 23, 2026 · Updated 29 times
Summary
This study tested the drug thalidomide in people with a rare disease called systemic mastocytosis, where too many mast cells build up in the body. The goal was to see if thalidomide could slow or stop the disease by cutting off its blood supply. The trial included adults whose disease had come back or gotten worse, and measured how much the disease improved after 6 months of treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON NEOPLASTIC CONDITION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Centre Hospitalier Universitaire d'Amiens
Amiens, 80054, France
Conditions
Explore the condition pages connected to this study.